🎗️June is Cancer immunotherapy month, and Clinakos Inc. nothing excites us more than getting to know about new breakthrough therapies and innovations in Oncology and Precision Medicine!

✨ In a recent study (April 2025), researchers have unveiled EchoBack-CAR T-cells—next-gen, ultrasound-controlled immune cells with game-changing benefits:

🔹 5x longer attack on tumor cells vs. standard CAR T-cells
🔹 Remotely activated by focused ultrasound for ultra-precise targeting
🔹 Fewer hospital visits—potentially just once every two weeks!
🔹 Smart safety: Deactivate outside tumors to protect healthy tissue
🔹 Feedback mechanism: Tumor cells trigger more cancer-fighting molecules
🔹 Ready for real-world use and adaptable for solid tumors like breast cancer & retinoblastoma

🚀 This innovation is a huge leap forward—bringing new hope to patients facing tough-to-treat cancers.

See the link to the original article: https://lnkd.in/gx76FNJ6

What excites you most about the future of immunotherapy and data-driven healthcare? Let’s connect and discuss! 👇

👉Reach out to us at https://lnkd.in/gp3gUmXc
👉Follow us at Clinakos Inc.